Scynexis SCYX
NASDAQ SCYX
$4.91 -0.24 (-4.66%)
At close: Sep 9, 2026 · 4:00 PM EDT

Scynexis (SCYX) Interest & Investment Income (2013 - 2026)

Scynexis' (SCYX) quarterly Interest & Investment Income came in at $685000.0 in Q2 2026, up 34.31% on a YoY basis from $510000.0 in Q2 2025, and up 28.04% quarter-over-quarter from $535000.0 in Q1 2026.

Analysis

Scynexis (SCYX) Interest & Investment Income (2013 - 2026) Analysis & Trends

Scynexis (SCYX) has reported Interest & Investment Income for 14 consecutive years, with $685000.0 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Interest & Investment Income rose 34.31% year-over-year to $685000.0; the trailing twelve-month figure through Jun 2026 stood at $2.1 million (down 34.11% YoY), and the FY2025 full-year result was $2.2 million, down 49.27% from the prior year.
  • Interest & Investment Income climbed to $685000.0 in Q2 2026 per SCYX's latest filing, from $535000.0 in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $1.4 million in Q4 2023 and bottomed at $13000.0 in Q1 2022.
  • Historically, Interest & Investment Income has averaged $724666.7 across 5 years, with a median of $688000.0 in 2022.
  • The sharpest annual moves came in 2022 and 2025: Interest & Investment Income soared 17175.0% in 2022, then sank 55.49% in 2025.
  • Over 5 years, Interest & Investment Income stood at $691000.0 in 2022, then surged by 97.4% to $1.4 million in 2023, then tumbled by 36.29% to $869000.0 in 2024, then plunged by 51.9% to $418000.0 in 2025, then soared by 63.88% to $685000.0 in 2026.
  • According to Business Quant data, Interest & Investment Income over the past three periods registered $685000.0, $535000.0, and $418000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn -
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn 120.60 Mn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn -48.00 Mn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn 48.00 Mn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn 67.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn 28.14 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn -
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn 36.92 Mn
10 Scynexis 58.41 Mn -56.29 Mn - 685,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 685,000.00
Mar 31, 2026 535,000.00
Dec 31, 2025 418,000.00
Sep 30, 2025 454,000.00
Jun 30, 2025 510,000.00
Mar 31, 2025 776,000.00
Dec 31, 2024 869,000.00
Sep 30, 2024 1.02 Mn
Jun 30, 2024 1.13 Mn
Mar 31, 2024 1.28 Mn
Dec 31, 2023 1.36 Mn
Sep 30, 2023 1.26 Mn
Jun 30, 2023 737,000.00
Mar 31, 2023 587,000.00
Dec 31, 2022 691,000.00
Sep 30, 2022 531,000.00
Jun 30, 2022 181,000.00
Mar 31, 2022 13,000.00
Dec 31, 2021 4,000.00
Sep 30, 2021 8,000.00